First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study

Background: The ALLEGRA (Biosensors International) transcatheter heart valve is a self-expanding supra-annular bovine pericardial aortic valve. A new delivery system (IMPERIA™, Biosensors International) has been designed which allows the valve to be fully resheathed and repositioned in situ. The aim...

Full description

Saved in:

Bibliographic Details
Main Authors:	José Antonio Baz, MD, Christof Burgdorf, MD, Christian Frerker, MD, Ignacio Cruz González, MD, Joan Antoni Gômez, MD, Joseph Graham, MD, José Maria Hernândez, MD, Pilar Jimenez, MD, Claire B. Ren, MD, Ernest Spitzer, MD, Pim Tonino, MD, Pieter Vriesendorp, MD, Nicolas van Mieghem, MD, Samuel Copt, PhD, Anders Jönsson, MD, Keith G. Oldroyd, MD, Nicolas Doll, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Structural Heart
Subjects:	Aortic valve stenosis Self-expanding heart valve Transcatheter aortic valve replacement
Online Access:	http://www.sciencedirect.com/science/article/pii/S2474870624001520
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study

Similar Items